Structured around integrated nanoparticle delivery and nucleic acid design, Tiba Biotech LLC is addressing development of life-saving vaccines and new areas of therapeutic impact: creation of a new generation of vaccines and immunotherapies for human and animal disease. Bridging expertise in synthetic biology and chemistry to bring more potent and cost-effective solutions to the market. the vision is of a world where affordable vaccines and therapeutics can be developed in response to epidemics and specific patient needs, without the need for protracted biomanufacturing processes. Engaged in early discovery of immuno-oncology and gene editing, the effort is to tackle a range of novel vaccines, with initial focus on the COVID-19 pandemic and the persistent challenge of seasonal influenza.
